Giovanni Monteleone and his colleagues show that the T cell-derived cytokine interleukin-21 is a new potential therapeutic target for psoriasis. Interleukin-21 seems to act directly on keratinocytes, stimulating them to proliferate and causing epidermal hyperplasia.
- Roberta Caruso
- Elisabetta Botti
- Giovanni Monteleone